These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33891423)

  • 1. Prodrug-Based Versatile Nanomedicine with Simultaneous Physical and Physiological Tumor Penetration for Enhanced Cancer Chemo-Immunotherapy.
    Guo Z; Hu Y; Zhao M; Hao K; He P; Tian H; Chen X; Chen M
    Nano Lett; 2021 May; 21(9):3721-3730. PubMed ID: 33891423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient PD-L1 gene silence promoted by hyaluronidase for cancer immunotherapy.
    Guan X; Lin L; Chen J; Hu Y; Sun P; Tian H; Maruyama A; Chen X
    J Control Release; 2019 Jan; 293():104-112. PubMed ID: 30476528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Self-amplifying ROS-sensitive prodrug-based nanodecoy for circumventing immune resistance in chemotherapy-sensitized immunotherapy.
    Zhang J; Sun X; Xu M; Zhao X; Yang C; Li K; Zhao F; Hu H; Qiao M; Chen D; Zhao X
    Acta Biomater; 2022 Sep; 149():307-320. PubMed ID: 35764242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A versatile strategy to create an active tumor-targeted chemo-photothermal therapy nanoplatform: A case of an IR-780 derivative co-assembled with camptothecin prodrug.
    He W; Jiang Y; Li Q; Zhang D; Li Z; Luan Y
    Acta Biomater; 2019 Jan; 84():356-366. PubMed ID: 30502480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor microenvironment-activated therapeutic peptide-conjugated prodrug nanoparticles for enhanced tumor penetration and local T cell activation in the tumor microenvironment.
    Zhu X; Li C; Lu Y; Liu Y; Wan D; Zhu D; Pan J; Ma G
    Acta Biomater; 2021 Jan; 119():337-348. PubMed ID: 33166712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-dilated polymersome nanofactories for enhanced enzyme prodrug chemo-immunotherapy.
    Japir AAMM; Ke W; Li J; Mukerabigwi JF; Ibrahim A; Wang Y; Li X; Zhou Q; Mohammed F; Ge Z
    J Control Release; 2021 Nov; 339():418-429. PubMed ID: 34662586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prodrug-Based Versatile Nanomedicine for Enhancing Cancer Immunotherapy by Increasing Immunogenic Cell Death.
    Bai S; Yang LL; Wang Y; Zhang T; Fu L; Yang S; Wan S; Wang S; Jia D; Li B; Xue P; Kang Y; Sun ZJ; Xu Z
    Small; 2020 May; 16(19):e2000214. PubMed ID: 32309900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prodrug nanoparticles potentiate tumor chemo-immunometabolic therapy by disturbing oxidative stress.
    Zhao H; Li Y; Shi H; Niu M; Li D; Zhang Z; Feng Q; Zhang Y; Wang L
    J Control Release; 2022 Dec; 352():909-919. PubMed ID: 36370878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trident Molecule with Nanobrush-Nanoparticle-Nanofiber Transition Property Spatially Suppresses Tumor Metastasis.
    Gao G; Jiang YW; Zhan W; Liu X; Tang R; Sun X; Deng Y; Xu L; Liang G
    J Am Chem Soc; 2022 Jul; 144(26):11897-11910. PubMed ID: 35731698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous Knockdown of Immune Suppressive Markers by Tumor Microenvironment-Responsive Multifaceted Prodrug Nanomedicine.
    Zhang L; Wang J; Cui H; Zheng H; Yin X; Lin J; Wang Y; Zhao Y; Li H; Chen Q
    ACS Appl Mater Interfaces; 2023 Mar; 15(10):12864-12881. PubMed ID: 36856003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy.
    Hou M; Gao YE; Shi X; Bai S; Ma X; Li B; Xiao B; Xue P; Kang Y; Xu Z
    Acta Biomater; 2018 Sep; 77():228-239. PubMed ID: 30006314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione-Responsive Nanoparticles of Camptothecin Prodrug for Cancer Therapy.
    Zhang L; Zhu L; Tang L; Xie J; Gao Y; Yu C; Shang K; Han H; Liu C; Lu Y
    Adv Sci (Weinh); 2023 Jan; 10(3):e2205246. PubMed ID: 36442854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic triple-combination therapy with hyaluronic acid-shelled PPy/CPT nanoparticles results in tumor regression and prevents tumor recurrence and metastasis in 4T1 breast cancer.
    Sun W; Du Y; Liang X; Yu C; Fang J; Lu W; Guo X; Tian J; Jin Y; Zheng J
    Biomaterials; 2019 Oct; 217():119264. PubMed ID: 31260883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity.
    Yang S; Shim MK; Kim WJ; Choi J; Nam GH; Kim J; Kim J; Moon Y; Kim HY; Park J; Park Y; Kim IS; Ryu JH; Kim K
    Biomaterials; 2021 May; 272():120791. PubMed ID: 33831739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomimetic Liposome with Surface-Bound Elastase for Enhanced Tumor Penetration and Chemo-Immumotherapy.
    Li YJ; Wu JY; Hu XB; Ding T; Tang T; Xiang DX
    Adv Healthc Mater; 2021 Oct; 10(19):e2100794. PubMed ID: 34160137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immune cocktail therapy to realize multiple boosting of the cancer-immunity cycle by combination of drug/gene delivery nanoparticles.
    Wu J; Chen J; Feng Y; Zhang S; Lin L; Guo Z; Sun P; Xu C; Tian H; Chen X
    Sci Adv; 2020 Sep; 6(40):. PubMed ID: 32998884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly Enhanced Antitumor Immunity by a Three-Barreled Strategy of the l-Arginine-Promoted Nanovaccine and Gene-Mediated PD-L1 Blockade.
    Hu Y; Lin L; Chen J; Hao K; Zhang S; Guo X; Guo Z; Tian H; Chen X
    ACS Appl Mater Interfaces; 2020 Sep; 12(37):41127-41137. PubMed ID: 32808767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-localized delivery of nanomedicine and nanovaccine augments the postoperative cancer immunotherapy by amplifying T-cell responses.
    Liu X; Feng Z; Wang C; Su Q; Song H; Zhang C; Huang P; Liang XJ; Dong A; Kong D; Wang W
    Biomaterials; 2020 Feb; 230():119649. PubMed ID: 31791843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioma-targeted multifunctional nanoparticles to co-deliver camptothecin and curcumin for enhanced chemo-immunotherapy.
    Wang Z; Wang X; Yu H; Chen M
    Biomater Sci; 2022 Mar; 10(5):1292-1303. PubMed ID: 35083994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor microenvironment-responsive prodrug nanoplatform via co-self-assembly of photothermal agent and IDO inhibitor for enhanced tumor penetration and cancer immunotherapy.
    Liu Y; Lu Y; Zhu X; Li C; Yan M; Pan J; Ma G
    Biomaterials; 2020 Mar; 242():119933. PubMed ID: 32151859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.